Pixium Vision (EPA:PIX) said today that its Iris II ‘bionic eye’ won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System.
The company’s epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. A computer processes images captured by the camera and transmits the data into a signal that’s transferred back and projected onto the intraocular implant. The incoming signal stimulates the optic nerve and generates images that the brain can interpret as visual signals.